Fielding, A. K., Rowe, J. M., Buck, G., Foroni, L., Gerrard, G., Litzow, M. R., . . . Goldstone, A. H. (2014). UKALLXII/ECOG2993: Addition of imatinib to a standard treatment regimen enhances long-term outcomes in Philadelphia positive acute lymphoblastic leukemia. American Society of Hematology.
Citação norma ChicagoFielding, Adele K., et al. UKALLXII/ECOG2993: Addition of Imatinib to a Standard Treatment Regimen Enhances Long-term Outcomes in Philadelphia Positive Acute Lymphoblastic Leukemia. American Society of Hematology, 2014.
MLA CitationFielding, Adele K., et al. UKALLXII/ECOG2993: Addition of Imatinib to a Standard Treatment Regimen Enhances Long-term Outcomes in Philadelphia Positive Acute Lymphoblastic Leukemia. American Society of Hematology, 2014.